Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Laura A. Levit"'
Autor:
Apostolia M. Tsimberidou, Laura A. Levit, Richard L. Schilsky, Steven D. Averbuch, Daniel Chen, John M. Kirkwood, Lisa M. McShane, Elad Sharon, Kathryn F. Mileham, Michael A. Postow
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Purpose To develop recommendations for clinical trial reporting that address the unique efficacy, toxicity, and combination and sequencing aspects of immuno-oncology (IO) treatments. Methods ASCO and the Society for Immunotherapy of Cancer (
Externí odkaz:
https://doaj.org/article/00fcda6541714e90a7d4b3def16e9979
Autor:
Institute of Medicine, Board on Health Care Services, Board on Health Sciences Policy, Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule, Lawrence O. Gostin, Laura A. Levit, Sharyl J. Nass
In the realm of health care, privacy protections are needed to preserve patients'dignity and prevent possible harms. Ten years ago, to address these concerns as well as set guidelines for ethical health research, Congress called for a set of federal
Autor:
Narjust Duma, Ana I. Velazquez, Idalid Franco, Lauren Kiel, Laura A. Levit, Caroline Schenkel, Kelsey Kirkwood, Sybil Green, Gladys Rodriguez
Publikováno v:
JCO Oncol Pract
This manuscript reviews the status of Hispanic/Latinx physicians in oncology, the benefits and challenges to achieving equitable representation, and potential solutions and actions to increase diversity in the oncology workforce. Persons of Hispanic/
Autor:
Rachel B. Jimenez, Caroline Schenkel, Laura A. Levit, Bonnie Hu, Xiudong Jennifer Lei, R. Donald Harvey, Vicki A. Morrison, Teri Pollastro, David Waterhouse, Colin Weekes, Grant R. Williams, Suanna Bruinooge, Elizabeth Garrett-Mayer, Jeffrey Peppercorn
Publikováno v:
JCO oncology practice. 18(11)
PURPOSE: Treatment goals for patients with metastatic cancer include prolongation and maintenance of quality of life. Patients and oncologists have questioned the current paradigm of initial dose selection for systemic therapy; however, data on oncol
Publikováno v:
Ethicshuman researchREFERENCES. 44(5)
Research biopsies included in cancer clinical trials have the goal of advancing scientific understanding of the biological bases of cancer and its treatments, but may offer no prospect of direct benefit to participants and often pose more than minima
Autor:
Melinda Kaltenbaugh, Elizabeth Garrett-Mayer, Heidi D. Klepin, Priscila Hermont Goncalves, Dawn L. Hershman, Robert S. Miller, Laura A. Levit, Allison Magnuson, Suanna S. Bruinooge
Publikováno v:
Journal of Geriatric Oncology. 12:851-854
Autor:
Caroline Schenkel, Laura A. Levit, Sheetal Mehta Kircher, Kelsey Kirkwood, Trevor J. Royce, Kathryn Levit
Publikováno v:
JCO Oncol Pract
Pharmacy benefit managers (PBMs) are thoroughly integrated into the drug supply chain as administrators of prescription drug benefits for private insurers, self-insuring business, and government health plans. As the role of PBMs has expanded, their o
Autor:
Laura A. Levit, Shaily Arora, Paul G. Kluetz, Allison Magnuson, Atiqur Rahman, R. Donald Harvey
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(10)
Autor:
Kelsey Kirkwood, Sybil Green, Caroline Schenkel, Laura A. Levit, Michal Tibbits, Lori J. Pierce, Eileen Melnick, Karen M. Winkfield
Publikováno v:
JCO Oncology Practice. 17:224-226
Publikováno v:
Journal of Geriatric Oncology. 11:151-153